Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 5
2012 1
2013 3
2014 3
2015 3
2016 2
2017 1
2018 6
2019 4
2020 4
2021 10
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Xenotransplantation: A New Era.
Carrier AN, Verma A, Mohiuddin M, Pascual M, Muller YD, Longchamp A, Bhati C, Buhler LH, Maluf DG, Meier RPH. Carrier AN, et al. Among authors: muller yd. Front Immunol. 2022 Jun 9;13:900594. doi: 10.3389/fimmu.2022.900594. eCollection 2022. Front Immunol. 2022. PMID: 35757701 Free PMC article. Review.
Next-generation regulatory T cell therapy.
Ferreira LMR, Muller YD, Bluestone JA, Tang Q. Ferreira LMR, et al. Among authors: muller yd. Nat Rev Drug Discov. 2019 Oct;18(10):749-769. doi: 10.1038/s41573-019-0041-4. Epub 2019 Sep 20. Nat Rev Drug Discov. 2019. PMID: 31541224 Free PMC article. Review.
Xenotransplantation: back to the future?
Meier RPH, Muller YD, Balaphas A, Morel P, Pascual M, Seebach JD, Buhler LH. Meier RPH, et al. Among authors: muller yd. Transpl Int. 2018 May;31(5):465-477. doi: 10.1111/tri.13104. Epub 2018 Jan 4. Transpl Int. 2018. PMID: 29210109 Free article. Review.
[CAR-T therapy for autoimmune diseases].
Alcaraz-Serna A, Porret R, Trueb L, Ribi C, Seebach J, Muller YD. Alcaraz-Serna A, et al. Among authors: muller yd. Rev Med Suisse. 2024 Apr 3;20(868):688-693. doi: 10.53738/REVMED.2024.20.868.688. Rev Med Suisse. 2024. PMID: 38568061 Review. French.
Chimeric antigen receptor T-cell therapy for HIV cure.
Alfageme-Abello O, Porret R, Perreau M, Perez L, Muller YD. Alfageme-Abello O, et al. Among authors: muller yd. Curr Opin HIV AIDS. 2021 Mar 1;16(2):88-97. doi: 10.1097/COH.0000000000000665. Curr Opin HIV AIDS. 2021. PMID: 33560017 Review.
[Human diseases caused by Anisakis simplex].
Ringwald M, Muller YD, Ribi C. Ringwald M, et al. Among authors: muller yd. Rev Med Suisse. 2022 Apr 6;18(776):634-638. doi: 10.53738/REVMED.2022.18.776.634. Rev Med Suisse. 2022. PMID: 35385613 French.
[Hymenoptera venom allergy: what's new in 2023].
Belkoniene M, Ringwald M, Leimgruber A, Muller YD. Belkoniene M, et al. Among authors: muller yd. Rev Med Suisse. 2023 Apr 5;19(821):663-667. doi: 10.53738/REVMED.2023.19.821.663. Rev Med Suisse. 2023. PMID: 37017347 Review. French.
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A, Mohiuddin M, Manuel O, Vrakas G, Maluf DG, Buhler LH, Muller YD, Pascual M. Meier RPH, et al. Among authors: muller yd. Xenotransplantation. 2021 May;28(3):e12681. doi: 10.1111/xen.12681. Epub 2021 Mar 23. Xenotransplantation. 2021. PMID: 33759229 Review.
60 results